In this issue:  Science   |  Abstracts  |  Industry News   |  Policy

Subscribe   |   Unsubscribe   


TOP STORIES

ESC_IS2

Embryonic Stem Cells from Rats Derived
University of South Carolina researchers, for the first time, have derived authentic embryonic stem cells from rats. This breakthrough finding will enable scientists to create far more effective animal models for the study of a range of human diseases.




SCIENCE

ESCSS2

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

Hebrew University of Jerusalem-Hadassah Medical Scientists Reveal Mechanism that Triggers Differentiation of Embryo Cells
The mechanism whereby embryonic cells stop being flexible and turn into more mature cells has been discovered by scientists at the Hebrew University of Jerusalem.

VIDEO: Fusing Embryonic Stem Cells with Adult Cells Using Highly Efficient New Fusing System
MIT engineers have developed a new, highly efficient way to pair up cells so they can be fused together into a hybrid cell, for example, fusing an adult cell and an embryonic stem cell allows researchers to study the genetic reprogramming that occurs in such hybrids.

Functional Vasculature Generated from Advanced Cell Technology's Human Embryonic Stem Cells  
Advanced Cell Technology, Inc. reported that it is feasible to differentiate human embryonic stem cells into functional human vasculature and that they have the potential for both endothelial cell and vascular smooth muscle cell lineage differentiation.

Hebrew University of Jerusalem-Hadassah Medical Scientists Succeed Through Stem Cell Therapy in Reversing Brain Birth Defects
Scientists at the Hebrew University of Jerusalem have succeeded in reversing brain birth defects in animal models, using stem cells to replace defective brain cells.




ABSTRACTS

Integrated Chemical Genomics Reveals Modifiers of Survival in Human Embryonic Stem Cells
The researchers in this paper developed a high content screening approach with small molecules to examine hESC survival.

Human Embryonic Stem Cells with Maintenance under a Feeder-Free and Recombinant Cytokine-Free Condition
This paper shows that human embryonic stem cells could be maintained under a feeder-free condition without using recombinant cytokines if sizes and numbers of ES colonies were kept within an appropriate range.




INDUSTRY

VistaGen and WARF Sign License Agreement for Human Embryonic Stem Cell Technology
VistaGen Therapeutics and the Wisconsin Alumni Research Foundation have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools.

Novocell Announces Non-Exclusive Drug Discovery Collaboration with Pfizer Research to Utilize Novocell's Stem Cell-derived Pancreatic Progenitor Cells
Novocell, Inc. recently announced it has entered into a non-exclusive drug discovery collaboration with Pfizer giving Pfizer access to Novocell's proprietary pancreatic progenitor cells derived from human embryonic stem cells.

Madison Stem Cell Researchers Get $50,000 State Grant
A Madison company that is developing a better way to grow stem cells has received a $50,000 grant from the state, the governor's office confirmed late recently.

Seoul National University Drops Bid for Stem Cell Patent
Seoul National University has decided to make no more efforts to obtain overseas patents for the controversial stem cell production technology of disgraced scientist Hwang Woo-suk.




POLICY

California Stem Cell Agency Faces Cash Freeze
The global financial crisis may do what opponents of California's $3 billion state-sponsored stem cell research experiment could not: dry up funding.

Missouri Group Refiles Initiative to Ban Using Taxes for Abortion, Human Cloning
Missouri Roundtable for Life seeks a November 2010 vote on a proposed state constitutional amendment saying "it shall be unlawful to expend, pay, or grant any public funds for abortion services, human cloning or prohibited human research."

Democrats Debate Methods to End Stem Cell Ban
Thwarted by President Bush in their efforts to expand federal spending on embryonic stem cell research, Democrats are now debating whether to overturn federal restrictions through executive order or by legislation when they assume full control of the government this month.



 Learn more about Embryonic Stem Cell News:  Archives  |  Events   |  Subscribe   |  Contact Us
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada